Tag: CBT > Cannabis Schedule

Cannabis Business Insurance

US Lawmakers Introduce Bill to Assist Cannabis Businesses in Getting Insurance

The bipartisan legislation aims to shield insurance companies that serve the cannabis industry from federal prosecution and liability.

September 17, 2026

Cannabis Rescheduling

Where Are We on Cannabis Rescheduling? It’s Been Months Since the US Attorney General’s April 2026 Order

There’s been no transparency about the applications of those seeking DEA registration. The IRS/Treasury has provided no guidance about what to do regarding §280E on those federal tax returns – even though, in April, the feds promised it would be forthcoming.

September 11, 2026

Cannabis Rescheduling

Federal Court Denies Anti-Rescheduling Parties’ Motion to Stay Schedule III Cannabis Order

The U.S. Court of Appeals for the District of Columbia Circuit won’t halt the Trump administration’s order that reclassified medical cannabis.

September 10, 2026

Cannabis Rescheduling

Will Judge’s Rescheduling Decision Be Influenced by Lone Opposed Party Witness DEA Did Not Discredit?

Some legal experts believe a pharmacologist’s testimony on currently accepted medical use could be the most damning for the Schedule III proposal.

August 28, 2026

Cannabis Rescheduling

DEA Judge Orders 294 Corrections to 2,500-Page Cannabis Hearing Transcript

The DEA’s administrative law judge said the fully corrected transcript for the cannabis rescheduling hearing will be made public no later than Aug. 26.

August 21, 2026

Cannabis Rescheduling

Prohibitionists Punch Back at Cannabis Rescheduling Hearing

Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.

July 1, 2026

Cannabis Rescheduling

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

June 26, 2026

Cannabis Rescheduling

DEA Judge Sets Cannabis Hearing Schedule, Won’t Consider More Participants

The administrative law judge declined to consider pleas from non-parties to participate in the rescheduling hearing for the proposed Schedule III rule.

June 25, 2026

Cannabis Rescheduling

Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?

The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.

June 24, 2026

Cannabis Rescheduling

DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties

Derek C. Julius will be the DEA’s chief administrative law judge to oversee the hearing of a proposed rule to reclassify cannabis as a Schedule III drug.

June 19, 2026

Hemp-Derived Cannabinoids

White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May

The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.

May 27, 2026

Cannabis Rescheduling

3 Immediate Implications of Schedule III Leads CBT’s Top Stories in April

Vicente LLP founding partner Brian Vicente broke down the implications, and what else may unfold, in this month’s most-read article.

April 29, 2026